Clinical Trials on Specific Antibody Deficiency

Total 10795 results

Cancer Research UK

Completed

Geldanamycin Analogue in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

T138067 Sodium in Treating Patients With Advanced Refractory Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Polyglutamate Camptothecin in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Combination Chemotherapy In Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Sirius Medicine

Completed

Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Jewish General Hospital
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants (IRB 2004-535)

Unspecified Adult Solid Tumor, Protocol Specific

United States, United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Etoposide and Celecoxib in Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

BMS-599626 in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Astex Pharmaceuticals, Inc.

Completed

Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

Unspecified Adult Solid Tumor, Protocol Specific

United States
European Organisation for Research and Treatment...

Completed

Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care

Unspecified Adult Solid Tumor, Protocol Specific

France, United Kingdom, Belgium, Spain, Sweden
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Study of Hair Samples From Patients With Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Georgetown University
National Cancer Institute (NCI)

Completed

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

SU5416 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

SU5416 and Paclitaxel in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

BMS-214662 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Unknown

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

Unspecified Adult Solid Tumor, Protocol Specific
University of Saskatchewan
Heart and Stroke Foundation of Canada

Completed

Examining Physician Counseling to Promote Adoption of Physical Activity: A Controlled Trial

No Specific Conditions Are Being Examined
Turtle Shell Technologies Pvt. Ltd.

Recruiting

Non-invasive Monitoring: Impact on Patient Management and Outcomes

No Specific Medical Conditions or Disease States

United States
Charite University, Berlin, Germany

Recruiting

Effects of Forest Therapy on Physical and Psychological Parameters in the General Population - a Randomized Controlled Trial

General Population (no Specific Condition or Disease)

Germany
Children's Hospital Los Angeles

Recruiting

Liquid Biopsies in Pediatric Solid Tumors

Pediatric Solid Tumor, Unspecified, Protocol Specific

United States
University of Nebraska
National Cancer Institute (NCI)

Completed

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute
TetraLogic Pharmaceuticals

Terminated

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Turtle Shell Technologies Pvt. Ltd.
Eastside Research Associates; HealthMinds

Completed

Pilot Evaluation of an Continuous Contactless Vitals Parameter Monitoring System Dozee VS

No Specific Medical Conditions or Disease States

United States
Turtle Shell Technologies Pvt. Ltd.
Louisiana State University Health Sciences Center in New Orleans; HealthMinds

Terminated

Pilot Clinical Evaluation of Dozee VS, a Contactless Continuous Vital Parameters Monitoring System in Hospital Patients (DZUSFDA21)

No Specific Medical Conditions or Disease States

United States
Nektar Therapeutics

Completed

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors (NKTR-214)

Unspecified Adult Solid Tumor, Protocol Specific

United States
Assistance Publique - Hôpitaux de Paris

Withdrawn

Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin By French-speaking Patients

The Study Focus on no Specific Condition

France
Assistance Publique - Hôpitaux de Paris

Withdrawn

Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin by French-speaking Population

The Study Focus on no Specific Condition

France
Assistance Publique - Hôpitaux de Paris

Withdrawn

Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin by English-speaking Population*

The Study Focus on no Specific Condition

France
Assistance Publique - Hôpitaux de Paris

Unknown

A Vignette-based Randomized Controlled Trial to Evaluate the Impact of Supervisor's Role on Research Practices of Doctoral Students

The Study Focus on no Specific Condition
Mbarara University of Science and Technology
University Ghent; Free University of Brussels

Unknown

Mitigating Adverse Sexual and Reproductive Health Outcomes Among Young Adolescents

Relationship Problems Specific to Childhood and Adolescence
Assistance Publique - Hôpitaux de Paris

Unknown

Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin by English-speaking Population

The Study Focus on no Specific Condition

France
UMC Utrecht

Completed

A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03) (CPCT-03)

Unspecified Adult Solid Tumor, Protocol Specific

Netherlands
University of California, Davis
Bayer

Completed

Sorafenib in Treating Patients With Advanced Malignant Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Southern California
National Cancer Institute (NCI); Jina Pharmaceuticals Inc.

Completed

Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Genentech, Inc.
National Cancer Institute (NCI); Sidney Kimmel Comprehensive Cancer Center...

Completed

GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
Southwest Oncology Group
National Cancer Institute (NCI)

Withdrawn

S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)

Completed

Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants

Unspecified Childhood Solid Tumor, Protocol Specific

United States, Canada, Australia
National Cancer Institute (NCI)

Completed

SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Unspecified Adult Solid Tumor, Protocol Specific

United States

Clinical Trials on Specific Antibody Deficiency

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations